NASDAQ:CYCN | Key Financial Ratios | Cyclerion Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-300.82-96.78%-131.85%
2026-03-311.8-62.03%-77.69%
2025-12-315.15-35.33%-38.83%
2025-09-305.78-21.11%-23.06%
2025-06-305.03-20.77%-22.71%
2025-03-314.21-29.90%-33.53%
2024-12-315.83-31.93%-34.54%
2024-09-305.07-59.35%-64.42%
2024-06-303.6829.89%34.25%
2024-03-314.171.31%1.50%
2023-12-313.85-39.35%-46.62%
2023-09-304.21-70.89%-83.78%
2023-06-301.44-285.70%-560.14%
2023-03-311.11-332.18%-969.53%
2022-12-311.94-243.81%-421.72%
2022-09-302.54-190.14%-288.29%
2022-06-303.22-137.54%-190.97%
2022-03-314.51-110.10%-138.32%
2021-12-315-76.18%-93.69%
2021-09-305.61-79.20%-95.15%
2021-06-306.94-80.78%-93.80%
2021-03-313.3-64.55%-133.23%
2020-12-313.45-67.43%-130.78%
2020-09-304.31-64.40%-112.31%
2020-06-303.81-72.74%-140.90%
2020-03-316.13-75.59%-129.82%
2019-12-315.55-65.96%-125.87%
2019-09-306.32-60.97%-107.26%
2019-06-306.6-55.13%-91.95%
2019-03-310.05-1303.08%1642.80%
2018-12-310.05-1557.25%1103.42%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-315.15-35.33%-38.83%
2024-12-315.83-31.93%-34.54%
2023-12-313.85-39.35%-46.62%
2022-12-311.94-243.81%-421.72%
2021-12-315-87.05%-107.05%
2020-12-313.45-67.43%-130.78%
2019-12-315.55-65.96%-125.87%
2018-12-310.05-1557.25%1103.42%